DK129991C - - Google Patents

Info

Publication number
DK129991C
DK129991C DK33073*#A DK33073A DK129991C DK 129991 C DK129991 C DK 129991C DK 33073 A DK33073 A DK 33073A DK 129991 C DK129991 C DK 129991C
Authority
DK
Denmark
Application number
DK33073*#A
Other languages
Danish (da)
Other versions
DK129991B (da
Inventor
K Irmscher
D Orth
H Nowak
Z Simane
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of DK129991B publication Critical patent/DK129991B/da
Application granted granted Critical
Publication of DK129991C publication Critical patent/DK129991C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
DK33073AA 1972-01-22 1973-01-19 Analogifremgangsmåde til fremstilling af vandopløselige sterolsulfater. DK129991B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722203048 DE2203048A1 (de) 1972-01-22 1972-01-22 Wasserloesliche sterinsulfate

Publications (2)

Publication Number Publication Date
DK129991B DK129991B (da) 1974-12-09
DK129991C true DK129991C (ja) 1975-05-20

Family

ID=5833749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK33073AA DK129991B (da) 1972-01-22 1973-01-19 Analogifremgangsmåde til fremstilling af vandopløselige sterolsulfater.

Country Status (17)

Country Link
US (1) US3836527A (ja)
JP (1) JPS4881847A (ja)
AT (1) AT323344B (ja)
AU (1) AU465860B2 (ja)
BE (1) BE794362A (ja)
BR (1) BR7300391D0 (ja)
CH (1) CH578019A5 (ja)
DD (1) DD102693A5 (ja)
DE (1) DE2203048A1 (ja)
DK (1) DK129991B (ja)
ES (1) ES410828A1 (ja)
FR (1) FR2181680B1 (ja)
GB (1) GB1367025A (ja)
HU (1) HU164290B (ja)
IL (1) IL41234A (ja)
NL (1) NL7217831A (ja)
ZA (1) ZA729168B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021458A (en) * 1974-04-18 1977-05-03 Schering Aktiengesellschaft Process for the preparation of 3-hemisulfate-17α-hydroxy steroids
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
DE19642875B4 (de) * 1996-10-17 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Sterolsulfaten
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
ATE314057T1 (de) * 1998-03-26 2006-01-15 Phytopharm Plc Smilagenin und anzurogenin-d zur behandlung der alzheimerischen krankheit
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
CA2508913A1 (en) * 2002-12-24 2004-07-15 The University Of British Columbia Angiogenic compounds and uses thereof
ITMI20030822A1 (it) * 2003-04-18 2004-10-19 Erregierre Spa Processo per la preparazione dell'acido ursodesossicolico
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
KR102530119B1 (ko) 2013-12-24 2023-05-08 버지니아 커먼웰스 유니버시티 산소첨가된 콜레스테롤 술페이트 (ocs) 의 용도
DK3494125T3 (da) 2016-08-02 2022-08-01 Univ Virginia Commonwealth Sammensætninger omfattende 5-cholesten-3, 25-diol, 3-sulfat (25HC3S) eller farmaceutisk acceptabelt salt deraf og mindst ét cyklisk oligosaccharid

Also Published As

Publication number Publication date
JPS4881847A (ja) 1973-11-01
DD102693A5 (ja) 1973-12-20
BE794362A (fr) 1973-07-23
FR2181680B1 (ja) 1975-10-10
FR2181680A1 (ja) 1973-12-07
HU164290B (ja) 1974-01-28
AT323344B (de) 1975-07-10
IL41234A0 (en) 1973-03-30
ZA729168B (en) 1973-09-26
ES410828A1 (es) 1976-04-16
IL41234A (en) 1976-05-31
BR7300391D0 (pt) 1973-10-25
AU5127873A (en) 1974-07-25
AU465860B2 (en) 1975-10-09
DK129991B (da) 1974-12-09
GB1367025A (en) 1974-09-18
DE2203048A1 (de) 1973-08-16
US3836527A (en) 1974-09-17
CH578019A5 (ja) 1976-07-30
NL7217831A (ja) 1973-07-24

Similar Documents

Publication Publication Date Title
SE7317323L (ja)
FR2181680B1 (ja)
JPS4962130A (ja)
JPS5527848B2 (ja)
JPS49589A (ja)
JPS4912982A (ja)
JPS4948391A (ja)
JPS4935613A (ja)
JPS4990911A (ja)
JPS4932907U (ja)
FR2188063B1 (ja)
JPS5040661Y2 (ja)
JPS535434Y2 (ja)
JPS4962043U (ja)
JPS4975498U (ja)
JPS4914704U (ja)
JPS4956858U (ja)
CH574065A5 (ja)
CH572990A5 (ja)
CH574743A5 (ja)
CH575379A5 (ja)
CH577497A5 (ja)
CH576179A5 (ja)
CH576065A5 (ja)
CH574863A5 (ja)